US orders warnings on weight-loss drugs over rare eye condition
· 50-word read
In 50 words
The US Food and Drug Administration has ordered makers of GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, to add warnings about NAION, a rare eye condition that can cause sudden vision loss that may be permanent. Novo Nordisk says data do not prove cause and effect.
Advertisement
Why it matters
The warning covers widely used diabetes and weight-loss drugs. The American Academy of Ophthalmology advises patients not to stop their medication without talking to a doctor, and to see an eye specialist promptly if sudden vision loss occurs.
Ask BangkokScoop AI about this story
Sources
Advertisement
